Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
J Cereb Blood Flow Metab. 2021 Jun;41(6):1193-1209. doi: 10.1177/0271678X20970059. Epub 2021 Jan 14.
Targeted temperature management (TTM) is a recommended neuroprotective intervention for coma after out-of-hospital cardiac arrest (OHCA). However, controversies exist concerning the proper implementation and overall efficacy of post-CA TTM, particularly related to optimal timing and depth of TTM and cooling methods. A review of the literature finds that optimizing and individualizing TTM remains an open question requiring further clinical investigation. This paper will summarize the preclinical and clinical trial data to-date, current recommendations, and future directions of this therapy, including new cooling methods under investigation. For now, early induction, maintenance for at least 24 hours, and slow rewarming utilizing endovascular methods may be preferred. Moreover, timely and accurate neuro-prognostication is valuable for guiding ethical and cost-effective management of post-CA coma. Current evidence for early neuro-prognostication after TTM suggests that a combination of initial prediction models, biomarkers, neuroimaging, and electrophysiological methods is the optimal strategy in predicting neurological functional outcomes.
目标温度管理(TTM)是一种推荐的神经保护干预措施,用于治疗院外心脏骤停(OHCA)后的昏迷。然而,关于 CA 后 TTM 的正确实施和总体疗效仍存在争议,特别是与 TTM 的最佳时机和深度以及冷却方法有关。文献回顾发现,优化和个体化 TTM 仍然是一个悬而未决的问题,需要进一步的临床研究。本文将总结迄今为止的临床前和临床试验数据、当前的建议以及该疗法的未来方向,包括正在研究的新冷却方法。目前,早期诱导、至少维持 24 小时以及利用血管内方法缓慢复温可能是首选方法。此外,及时准确的神经预后评估对于指导 CA 后昏迷的伦理和具有成本效益的管理是有价值的。目前关于 TTM 后早期神经预后的证据表明,初始预测模型、生物标志物、神经影像学和电生理方法的组合是预测神经功能结局的最佳策略。